Trial Details
TERMINATEDBasic Information
| Clinical ID | c4134 |
|---|---|
| Identifier | NCT01009281 |
| Trial Title | An Open Label Safety and Tolerability Study of AIN457 in Patients With Moderate to Severe Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Crohn's Disease|Inflammatory Bowel Disease |
| Interventions | DRUG: AIN457 |
Participant Information
| Sponsor | Novartis Pharmaceuticals |
|---|---|
| City | Bristol |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2009-10-30 |
|---|---|
| Primary Completion Date | 2010-08-19 |
| Completion Date | 2010-08-19 |